Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
More specific conditions that are subtypes of Doxorubicin in the MeSH hierarchy.
3 drugs approved
Phase 4 trials (1)
Phase 3 trials (11)
Phase 2 trials (2)
Other trials (3)